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Abstract 
 It is important to analyze patterns of risk factors associated with congestive heart failure 
(CHF) readmission rates. Today, if a CHF patient is readmitted within 30 days of their initial 
discharge the hospital will not be reimbursed for the stay. The aims of this study are to see if there 
is an association between patients readmitted within 30, 60, and 90 days of the initial discharge and 
to identify patterns of risk factors associated with CHF readmissions. A search of the CINAHL 
research database was conducted, using the key words “heart failure”, “signs and symptoms”, 
“readmission rates” and “comorbidities”. The study was a retrospective chart review that consisted 
of a randomized sample of 52 patients readmitted from 2012-2014 with a primary diagnosis of 
congestive heart failure. Results showed there was a significant association between 30 and 60 day 
readmissions, but not 30 and 90 day readmissions. Identified risk factors included sex, overt clinical 
symptoms (dyspnea, fatigue and weakness, edema) and ejection fractions.  
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Identifiable Risk Factors Associated with Congestive Heart Failure Hospital Readmissions 
The leading cause of hospitalization and death in people age 60 years of age and over is 
congestive heart failure (CHF). There are more than 1 million hospital admissions for this condition in 
the United States annually. (10) Reducing the readmission rate to hospitals has become an increasingly 
important task. (21) A common timeframe to measure readmission used by Centers for Medicare and 
Medicaid services (CMS) is 30 days of the index hospitalization. While some cases of readmission are 
unpreventable, the majority are considered to be due to poor clinical outcomes suggesting the patient 
was discharged too early or that optimal patient education was not achieved. (1)  
              Congestive Heart failure (CHF) is a condition where the heart fails to pump an adequate amount 
of blood to the body. CHF normally occurs when another condition has weakened the heart to the point 
where it can no longer keep up with the demands of body tissues. Pathology such as coronary artery 
disease, hypertension, faulty heart valves, cardiomyopathy, myocarditis, myocardial infarction, 
congenital heart defects and heart arrhythmias can predispose patients to CHF. While CHF is a 
significant threat to a patient’s health, it is possible to live with CHF if the disease is properly managed. 
Patients suffering from unmanaged CHF strain healthcare resources due to frequent readmissions 
associated with high costs of care. Identifying risk factors associated with CHF readmission rates is 
crucial in the effort to decrease this pattern. Once patterns of risk factors are identified, patient specific 
interventions can be planned and implemented. (6)  
The southeastern United States (Alabama, Arkansas, Mississippi, Oklahoma, Louisiana, and 
Georgia) has commonly been referred to as the “stroke belt” of the nation. Now research is concluding 
that CHF may also be more common in these identified states. In the latest statistical analysis, the 
southeastern United States showed higher numbers of CHF patients indicating these states are also now 
living in the “Heart Failure Belt”. (2) 
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Literature Review 
Patient factors contributing to CHF readmission  
  Readmissions to the hospital within 30 days of a previous discharge are responsible for 24% of 
all Medicare expenditures, adding up to approximately $2 billion annually. (19) Patients discharged with 
CHF are strongly associated with hospital 30-day readmission. Identifying and controlling common risk 
factors is crucial to alleviate the financial burden and to better manage the patient’s disease. (19) In a 
survey assessing patient characteristics associated with chronic disease including CHF the average age of 
respondents was 77. Of those, 83% had a pension card, 53% had an income less than $20,000 a year, 
41% had no formal education qualifications, 31% reported having no access to a car for transportation, 
over 34% lived alone, 22% did not have a close friend or relative who regularly took care of them, 68% 
reported poor health, and 53% of participants had mild to severe psychosocial stress.  This study found 
that programs dedicated to targeting medication adherence, health behaviors, and social isolation 
helped reduce the readmission rates associated with elderly patients with chronic diseases. (17) 
 Assessment of comorbidities associated with CHF can help determine a patient’ risk for hospital 
readmission. One study found the most frequent comorbidities associated with CHF readmissions were 
diabetes (34%), previous myocardial infarction (13.8%), atrial fibrillation (34%), chronic obstructive 
pulmonary disease (26.1%), and renal disease (14.4%). This same study determined the most common 
risk factors associated with 7-day readmission (time in which readmission is most avoidable) were 
kidney diseases, discharge requiring home care services, and discharge against medical advice. (3)  
While looking at patient comorbidities is important, it is also necessary to take into account 
what happens at home once the patient is discharged. One study found patients most likely to be 
readmitted in the first two weeks of discharge were sicker, less compliant with prescribed medication, 
and received home-care that was not up to standard for CHF. Along with this, it speculated that social 
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work activity is needed to perform extensive assessments of day-to-day needs post discharge and 
arrangements to meet those needs. (11, 18) The use of a multidisciplinary team post-discharge is a key 
component in the goal to keep the patient from being readmitted. Stewart and coworkers found that a 
specialized cardiac nurse is the best provider for home follow up care because the nurse can provide a 
realistic picture of the patient’s response to the prescribed treatment and management. (22) 
Hospital factors contributing to CHF readmission  
  There are factors associated with hospital structure and processes that can increase or decrease 
the risk of CHF patient readmission. Joynt and colleagues found patients discharged from facilities with a 
higher volume of CHF patients received a higher quality of care specific to their disease process and 
were less likely to be readmitted than patients discharged from hospitals that did not have a high 
volume of CHF patients. The downside to this finding is that hospitalization costs in hospitals with high 
volume of CHF patients were higher. . More research is needed to determine if the higher costs of 
providing CHF care in the high-volume hospitals are offset by the lower readmission rates. (8) 
Researchers have found that patients discharged from a cardiac specific unit are less likely to be 
readmitted than patients discharged from a general medical unit. Several reasons may account for this 
difference. Cardiac nurses are more familiar with CHF and patients are more likely to be discharged with 
CHF education from a heart failure outpatient team. Additionally patients on a cardiac specialty unit 
receive care from healthcare teams dedicated to cardiac health. (17) There are some factors affecting 
CHF patient readmissions however, that are difficult to measure such as whether the patients primary 
care provider is comfortable in dealing with the severity of the patient’s condition, and whether the 
patient’s family and/or friends are available to assist in the care of the patient. In some circumstances 
patients may be readmitted for tests and procedures which may be safer and easier to perform in the 
inpatient setting than in an outpatient setting. (5) Hospital Based CHF disease management programs 
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have been successful reducing hospital readmissions when inpatient consolation and education, 
outpatient CHF clinic, cardiac home care, and compliance monitoring are available. (4, 9)  
Signs and Symptoms Associated with CHF  
  Because there is no gold standard in the diagnosis of CHF, it is important for healthcare 
providers to recognize key signs and symptoms of this syndrome.  In CHF, the ventricular walls endure a 
great amount of stress, hypertrophy, and excessive volume pressure. This stress results in the release of 
B-Type Natriuretic Peptide (BNP) and N-Terminal proBNP (NT-proBNP) into the blood stream. These 
markers are elevated in patients with heart failure and low levels help rule out patients who do not have 
heart failure. These markers are also useful in monitoring the effectiveness of treatment and decrease 
with successful therapeutic management. (16). In a systemic review of BNP and NT-proBNP researchers 
found that in emergency departments or urgent care centers these markers are better for ruling out 
than ruling in heart failure. They also found that these markers were very beneficial in the primary care 
setting to identify patients at risk for developing heart failure (16).   
 One prevalent sign of heart failure is a lowered left ventricular ejection fraction. It is preferred 
for patients to have an ejection fraction of 60% or greater. In patients with worsening heart failure, their 
ejection fraction can become lower than 15% (15). Although a low ejection fraction is a key feature in 
the diagnosis of heart failure, it is also important to note that not all heart failure patients have a 
decreased ejection fraction.  Heart failure can be classified as either HF with preserved ejection fraction 
(HF-PEF) and HF with reduced ejection fraction (HF-REF). Treatment for these two groups of patients 
differs so it is important for heart failure patients to have their ejection fraction measured. Although the 
treatments between the two groups are different, a study from Dubai found no difference in mortality 
rates between the two and hospital stay between the groups was very similar.  Ischemic heart disease 
was the main cause of HF-REF while asthma and COPD were mostly associated with HF-PEF. Previously it 
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was thought HF-PEF was a misdiagnosis of respiratory disease. However, today use of NT-proBNP can 
differentiate heart failure from respiratory insufficiencies (20).   
 A majority of heart failure readmissions are associated with fluid retention and congestion; with 
the greater the fluid retention the more likely the patient is to be readmitted. Fluid retention leads to 
edema, dyspnea, and fatigue. These are the most common symptoms among heart failure emergency 
room visits and readmissions. One study found early dyspnea relief was one of the most important 
factors in saving heart failure patients from expensive readmissions (14). One of the best ways for a 
patient to know if he or she is retaining fluid is to perform daily morning weights.  Non-compliance with 
daily weights has been associated with an increase in both morbidity and mortality in heart failure 
patients (13). Researchers at the University of North Carolina conducted a study to determine if self-
reported recall of weight changes verses diary logs of weights had an impact on readmission rates. They 
found that 80% adherence to a diary weight log was associated with fewer readmissions, while self-
reported recall of weighs did not produce any decrease in readmission (7). It is important for clinicians 
and patients alike to be knowledgeable of and track the associated signs and symptoms of heart failure 
exacerbation to decrease readmission to the hospital. 
Study Aims 
The aim of this study was to identify patterns in readmissions and risk factors in CHF patients 
who required readmission to the hospital within 30 days, 60 days, and 90 days of the initial hospital 
discharge with the primary diagnosis of CHF.  
Study Questions: 
1. Is there an association between patients readmitted to the hospital within 30 days, 60 days, and 
90 days?  
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2. Do the patients readmitted to the hospital within 30 days, 60 days, and 90 days present a 
pattern of risk factors? 
Methodology 
This quality improvement project was conducted following approval by the University of 
Arkansas Institutional Review board and Washington Regional Medical Center’s Quality Improvement 
Department. All patient information was de-identified in compliance with guidelines of the Health 
Insurance Portability and Accountability Act (HIPAA). Each patient was assigned a random case number 
as an identifier. Once the patient’s electronic medical record was reviewed, the hospital record could 
not be identified or accessed again.  
Project Design and Population. This project consisted of a retrospective medical records 
review of patients readmitted to Washington Regional Medical Center following their initial e 
hospitalization with the primary diagnosis of CHF between the years of 2012-2014. The project sample 
consisted of 52 adults over the age of 18 with a primary diagnosis of CHF. Patients whose primary 
diagnosis was not CHF were not included in the study. Pregnant women and children were also 
excluded.  Demographic data (e.g., age, sex, ethnicity), and insurance type (private, Medicare, self-pay) 
was extracted from the electronic medical records. Additionally, the ejection fraction, overt clinical 
symptoms (e.g., dyspnea, edema, fatigue and weakness) and medication compliance was tracked. 
Statistical analysis. Baseline characteristics were presented as frequency (percent) for 
categorical variables, as mean + SD for normally distributed continuous variables, and as median 
(interquartile range) for continuous variables with skewed distributions.  The chi-square test for 
association or a Fisher’s exact test (for cells having an expected count less than 5) was used to test the 
null hypothesis that there is no relationship between criterion and predictor variables. A p value of .05 
was used as the level of statistical significance. To determine the effect size the symmetric measure Phi 
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was determined.  A paired t-test was used to determine whether the mean difference between paired 
ejection fraction observations was statistically significantly different from zero.  
Results 
The randomized sample consisted of 52 patients with a primary diagnosis of CHF 
readmitted to the acute care setting within 30 days, 60 days, and/or 90 days of their initial 
discharge. Demographics of the sample included 33 males and 19 females. Results showed a 
primarily homogenous Caucasian sample in which only 1 patient was Hispanic and 1 patient who 
did not have a documented race. The average age of the group was 76.1 (SD=15.9). The sample 
consisted of 34 patients covered by Medicare, 5 patients by Medicaid, and 8 patients by private 
insurance. Thirty-four patients presented with a history of tobacco use and 10 patients were noted 
to be current smokers. 
Descriptive Statistics   
  The study population consisted of 54.0% of patients readmitted to the hospital within 30 days, 
42.9% of patients readmitted within 31-60 days, and 29.4% of patients readmitted from 61-90 days 
following initial discharge. (Figure 1) Only 1 patient in the study was readmitted within 30, 60, and 90 
days of the initial discharge. 
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Figure 1: Percent of readmissions and non-readmissions of patients whose primary 
diagnosis was CHF at 30, 60, and 90 days post initial hospitalization.  
 
Clinical Symptoms  
 
In the initial hospital stay 96.2% of patients presented with dyspnea, 84.6% presented with 
edema, and 92.3% presented with fatigue and weakness. We found patients readmitted within 30 days 
presented with dyspnea (96.2%), edema (84.6%), fatigue and weakness (92.3%). This trend was also 
seen in patients readmitted between 31-60 days of their initial readmission with dyspnea (95.7%, edema 
(82.6%, and fatigue and weakness (91.3%). Of patients readmitted 61-90 days following initial admission 
for CHF, dyspnea (93.3%) and fatigue and weakness (93.3%) continues to be major presenting symptoms 
with edema (66.7%) slightly less of a presenting symptom. (Figure 2) 
 
 
Figure 2. Percentage of presenting clinical symptoms of patients with a primary diagnosis of 
CHF on initial admission and readmission at 30, 60, and 90 days.  
Ejection Fraction  
 No significant difference was noted in the ejection fractions between the initial discharge 
(42.6%) and 30 day readmission in patients (43.2%, SD=19.59). However, ejection fractions of patients 
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who were readmitted at 31-60 days (33.7%, SD=17.88) and 61-90 days (11.67%, SD=17.54) 
demonstrated a decline from initial and 30 day readmission ejection fractions. (Figure 3) 
 
Figure 3. Mean ejection fractions of patients with a primary diagnosis of CHF during initial 
admission and at 30, 60, and 90 day readmissions.  
Paired initial ejection fractions were compared with 30, 60 and 90 day readmissions. There were 
18 patients who were readmitted at 30 days who had ejection fractions documented upon initial CHF 
admission and at their 30 day readmission. Examination with a paired-samples t-test was used to 
determine whether there was a statistically significant mean difference between the initial ejection 
fraction and the 30 day readmission ejection fraction. No statistical significance was demonstrated.  
 Eighteen patients were admitted at 60 days post initial hospitalization and also had ejection 
fractions documented at the 60 day re-admission. A paired-samples t-test was used to determine 
whether there was a statistically significant mean difference between the initial ejection fraction and 
the 60 day readmission ejection fraction. No statistical significance was demonstrated.  
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 A total of 11 patients were admitted at 90 days post initial hospitalization and also had ejection 
fractions documented at the 90 day re-admission.  A paired-samples t-test was used to determine 
whether there was a statistically significant mean difference between the initial ejection fraction and 
the 90 day readmission ejection fraction. No statistical significance was demonstrated (Table 1). 
Table 1: Comparison of paired ejection fractions in between initial ejection fraction and 30, 60 and 90 
day readmissions. 
 
Comorbidities  
  Specific comorbidities included histories of chronic obstructive pulmonary disease (38.5%), 
moderate to severe renal disease (34.6%), type I or type II diabetes (32.7%), previous myocardial 
infarction (22%), cerebrovascular disease (21.2%), and peripheral vascular disease (19.2%). Additional 
 Mean t Df Sig (2--tailed 
30 day 
readmission 
(N=18) 
Initial EF 45.83 
(SD=18.17) 
1.57 17 .134 
30 day EF 43.22  
SD= 19.59) 
60 day 
readmission 
(N=18) 
Initial EF 36.33  
(SD= 17.55) 
2.008 17 .061 
60 day EF 33.83 
(SD=17.43) 
90 day 
readmission 
(N=11) 
Initial EF 37 (SD=15.96) .107 10 .917 
90 day EF 36.73 
(SD=18.43) 
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comorbidities included dementia (11.5%), connective tissue disease (5.8%) and peptic ulcer disease 
(1.9%). (Figure 4) 
 
Figure 4. Comorbidities noted in patient in the study.  
 
Initial and Readmission Associations   
A Chi-Square test for association was conducted to test the null hypothesis that there was no 
relationship between the 30 day readmission and 60 day and 90 day readmissions. Results indicated a 
significant association between 30 and 60 day readmissions[X2(1) = 14.14, p= .005]. A moderately strong 
association between 30 and 60 day readmission was noted (= -.543, p= .005).  
A Chi-Square test for association was conducted to determine if there was an association 
between 30-day readmission rates and 60 and 90-day readmission rates.  Results indicated a significant 
association between 30 and 60 day readmissions[X2(1) = 14.14, p= .005]. A moderately strong 
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association between 30 and 60 day readmission was noted μ = -.543, p= .005. (Figure 5) A Chi-Square 
test for association was conducted between 30 day and 90 day readmissions. There was no significant 
association between 30 day and 90 day readmissions. There was not a statistically significant difference 
between readmissions at 30 and 90 days post initial hospitalization. (Table 2) 
 
 
 
 
Table 2: 30-day * 60-day 
 
Chi-Square Tests 
  Value df 
Asymp. Sig. (2-
sided) 
Exact Sig. (2-
sided) 
Exact Sig. (1-
sided) 
Pearson Chi-Square 14.141a 1 .000     
Continuity Correctionb 11.955 1 .001     
Likelihood Ratio 14.961 1 .000     
Fisher's Exact Test       .000 .000 
Linear-by-Linear 
Association 
13.846 1 .000 
    
N of Valid Cases 48         
a. 0 cells (.0%) have expected count less than 5. The minimum expected count is 7.79. 
b. Computed only for a 2x2 table 
 
 
 
Table 3: 30-day * 90-day  
 
Chi-Square Tests 
  Value df 
Asymp. Sig. (2-
sided) 
Exact Sig. (2-
sided) 
Exact Sig. (1-
sided) 
Pearson Chi-Square .461a 1 .497     
Continuity Correctionb .125 1 .724     
Likelihood Ratio .460 1 .498     
Fisher's Exact Test       .532 .361 
Linear-by-Linear 
Association 
.451 1 .502 
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N of Valid Cases 48         
a. 0 cells (.0%) have expected count less than 5. The minimum expected count is 5.96. 
b. Computed only for a 2x2 table 
A chi-square test for association conducted between 30 day readmissions and insurance type 
demonstrated no significant association between 30 day readmissions and insurance type.  
A chi-square test for association was conducted between sex of the patients and 30-day 
readmissions. There was a statistically significant association between sex and 30 day readmission rates. 
[X² (1) =4.19, p=0.041].  There was a moderately strong association between sex and 30 readmissions. 
[μ= .296, p=.041] (Figure 5)  
 
Figure 5. Comparison of male versus female patients with a primary diagnosis of congestive 
heart failure readmitted at 30 days post initial hospitalization.  
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 It is important to note that the majority of subjects in this randomized sample were men. This is 
not a surprising finding because cardiovascular disease rates are higher in men than in women. Our 
sample group mean age of 76 coincides with the national statistics with the majority of patients in the 
hospital setting being over the age of 65. Our study sample proved to be a homogenous Caucasian 
(98%). Our random sample only contained 1 subject of Hispanic origin. The lack of inclusion of other 
ethnic backgrounds limits the generalizability of the study.  
  This study demonstrated a statistically significant increase in readmissions within 30 days of 
initial hospitalization. Patients in our study may have been in the plateau phase in their health or may 
have progressed to the phase where palliation and hospice care were in place. Palliation and hospice 
care could account for a decrease in readmission rates at 90 days. It is important to note that females in 
our study had significantly higher 30 day readmission rates than men. Results showed 75% of females 
were readmitted within 30 days, while only 43.8% of males were readmitted within 30 days. This could 
be associated with cardiovascular disease rates in men versus women. 
 It was hypothesized that insurance type may affect readmission rates; however, it was proven 
to be statistically insignificant.  
Challenges in Predicting CHF readmission  
As noted in the literature review, dyspnea, fatigue and weakness, and edema are key symptoms 
of a heart failure exacerbation. The results of the study align with the literature noting that the majority 
of the patients presented with dyspnea, fatigue, and weakness when admitted within 30 days, 60 days, 
and 90 days. Progressive renal impairment among other comorbidities has been increasingly recognized 
as potent predictors of adverse outcomes during readmission.  Additional associated diagnoses, 
including atrial fibrillation, ischemic heart disease, and hypertension also confer higher readmission 
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risks. Comorbidities such as diabetes, pulmonary disease and other non-cardiac illness may raise the risk 
for both heart failure and non-heart-failure-related complications. One unexpected finding was the 
percentage of readmissions when comparing 30 days, 60 days, and 90 days. It would be expected that 
patient readmissions would increase the longer they have been without acute care treatment, meaning 
the 61-90 day readmissions should have been the highest.  However, we found the opposite in that the 
highest percent of readmissions (54%) occurred within 30 days of the initial discharge. For an ejection 
fraction to be considered within normal limits it should be between 55 and 70%. The mean ejection 
fraction of patients readmitted within 30 days was found to be 43.2% well below normal. The mean 
ejection fraction continued to decrease at 60 day and 90 day readmissions. Patients readmitted within 
31-60 days had a mean ejection fraction of 33.7% and patients readmitted within 61-90 days had a 
mean ejection fraction of 11.7%, which is significantly lower than the normal level. However, when 
examining paired patient admissions from initial hospitalization to 30, 60 and 90 days no statistically 
significant difference in mean ejection fraction was noted. It is of interest that the only patient who was 
readmitted at 30, 60 and 90 days had an ejection fraction of 20% consistently with all three 
readmissions. 
Limitations  
 There were some limitations of the study. The randomized sample of 52 patients was relatively 
small; a larger sample may have provided different results. Another limitation of the study was involving 
the demographics of the Northwest Arkansas region. Readmission patterns related to race were unable 
to be identified due to lack of inclusion of other ethnic groups of patients. Also, tracking medication 
compliance was part of the project design; however, this was rarely charted so significance was unable 
to be determined. Patients were not followed individually to their “fate” within the study. Some patients 
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therefore may have entered palliative care, hospice, or died prior to the 90 day mark thus skewing 
results.  
Conclusion 
 In conclusion, there was a strong association between 30 day and 60 day readmissions; however 
there was no significant association between 30 day and 90 day readmissions. Over half of the sample 
was readmitted within 30 days, whereas only 29.4% were readmitted within 90 days. Female patients 
had a 31.2% higher rate of 30-day readmissions as compared to male patients. Of the 52 patients, 
diabetes and COPD were the most common comorbidities. Dyspnea, fatigue and weakness, and edema 
were presented in high rates among 30, 60 and 90 day readmissions. Effective strategies for preventing 
CHF readmissions must examine opportunities for management across the full continuum of the 
disease. Additional emphasis on discharge coordination, transitional care planning, and early follow-up 
by a heart failure clinic is needed. The presenting symptoms for rehospitalization included dyspnea, 
fatigue, and weakness and weight gain. Strategies to manage these presenting symptoms outside the 
hospital setting may impact the readmission rates of patients. 
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